Actuate Therapeutics, Inc.
ACTU
$1.95
$0.021.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.63M | -4.55M | -5.41M | -5.95M | -6.32M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.50M | 1.55M | 1.81M | 1.58M | 1.13M |
| Change in Net Operating Assets | -891.50K | -728.80K | -3.08M | 191.30K | 568.10K |
| Cash from Operations | -5.02M | -3.74M | -6.68M | -4.17M | -4.62M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 519.60K | 0.00 | 16.82M | 7.21M | -- |
| Repurchase of Common Stock | -527.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -29.30K | 289.50K | -429.50K | -133.50K |
| Cash from Financing | -8.10K | -29.30K | 17.11M | 6.78M | -133.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.03M | -3.77M | 10.43M | 2.60M | -4.75M |